| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |